CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex.
CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex.
复制标题
DOI:
10.1038/s12276-023-01085-y
复制
发表时间:
2023-09
影响因子:
12.8
通讯作者:
Shang, Xifu
中科院分区:
文献类型:
--
作者:
Chen, Kun;Chen, Xi;Lang, Chuandong;Yuan, Xingshi;Huang, Junming;Li, Zhi;Xu, Mingyou;Wu, Kerong;Zhou, Chenhe;Li, Qidong;Zhu, Chen;Liu, Lianxin;Shang, Xifu
The identification of key regulatory factors that control osteoclastogenesis is important. Accumulating evidence indicates that circular RNAs (circRNAs) are discrete functional entities. However, the complexities of circRNA expression as well as the extent of their regulatory functions during osteoclastogenesis have yet to be revealed. Here, based on circular RNA sequencing data, we identified a circular RNA, circFam190a, as a critical regulator of osteoclast differentiation and function. During osteoclastogenesis, circFam190a is significantly upregulated. In vitro, circFam190a enhanced osteoclast formation and function. In vivo, overexpression of circFam190a induced significant bone loss, while knockdown of circFam190a prevented pathological bone loss in an ovariectomized (OVX) mouse osteoporosis model. Mechanistically, our data suggest that circFam90a enhances the binding of AKT1 and HSP90β, promoting AKT1 stability. Altogether, our findings highlight the critical role of circFam190a as a positive regulator of osteoclastogenesis, and targeting circFam190a might be a promising therapeutic strategy for treating pathological bone loss. A newly discovered circular RNA molecule that promotes development of bone-degrading osteoclast cells offers a promising target for preventing skeletal degeneration in conditions like osteoporosis. Osteoclasts play a critical role in maintaining healthy bone density but excess activity can lead to eroded and fragile bone tissue. Several studies have suggested that gene-regulating circular RNAs play a role in osteoclast development, and Kun Chen of the University of Science and Technology of China, Hefei, and colleagues have identified one such molecule called circFam190a. They demonstrate that targeted inhibition of circFam190a can preserve bone integrity in a mouse model of osteoporosis without interfering with the activity of bone-generating osteoblast cells. The authors were also able to identify the broader network of signaling pathways influenced by circFam190a, which include several proteins with well-established roles in osteoclast function.
登录
查看更多内容
影响因子:
3.5
作者:
Haase M;Fitze G
通讯作者:
Fitze G
影响因子:
48
作者:
Langmead, Ben;Salzberg, Steven L.
通讯作者:
Salzberg, Steven L.
影响因子:
5.6
作者:
Chen K;Lv ZT;Cheng P;Zhu WT;Liang S;Yang Q;Parkman VA;Zhou CH;Jing XZ;Liu H;Wang YT;Lin H;Liao H;Chen AM
通讯作者:
Chen AM
影响因子:
5.6
作者:
Kim MJ;Kim HS;Lee S;Min KY;Choi WS;You JS
通讯作者:
You JS
影响因子:
4.8
作者:
Giustiniani, Julien;Daire, Vanessa;Baillet, Anita
通讯作者:
Baillet, Anita